Croda International (LON:CRDA) Rating Reaffirmed
Croda International (LON:CRDA) just had their share rating of a ‘”Buy”‘ issued by research analysts at Deutsche, who now has a GBX 3300.00 target on the 3.90B GBP market cap company or a 14.82% upside potential. This key information was shown in a comprehensive report on 3 December.
From a total of 17 analysts covering Croda International PLC (LON:CRDA) stock, 6 rate it a ”Buy”, 2 a “Sell”, and 9 a ”Hold”. This means that 35% of the ratings are positive. The highest target price is GBX 3400 while the lowest target price is GBX 1800. The mean of all analyst targets is GBX 2940.41 with a 5.02% above today’s (GBX 2872) stock price. Croda International PLC was the topic of 36 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Numis Securities maintained shares on December 2 with “Hold” rating. Goldman Sachs maintained shares with “Buy” rating and GBX 3400 target share price in a report from a November 30. JP Morgan maintained CRDA stock in a recent report from December 2 with “Neutral” rating. Investec maintained the rating on November 26. Investec has a “Hold” rating and a GBX 2800 price target on shares. Finally, BNP Paribas maintained the stock with “Neutral” rating in a report issued on a December 1.
Approximately 95,454 shares of stock traded hands. Croda International Plc (LON:CRDA) has risen 3.55% since May 6, 2015 and is uptrending. It has outperformed by 3.84% the S&P500.
Croda International Plc is a United Kingdom specialty chemical manufacturer. The company has a market cap of 3.90 billion GBP. The Company’s divisions include Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals. It has 22.32 P/E ratio. The Firm is a supplier of specialty ingredients for the personal care industry.